Jemperli-Us (Dostarlimab Ampoules) 500 mg/10ml

JEMPERLI-US (Dostarlimab) is an injectable prescription medicine used for certain cancer treatments. This 500 mg/10ml ampoule is stored at 2-8°C and requires professional handling. Always consult a healthcare provider for proper use and guidance.

Strength

500 mg/10ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dostarlimab is used to treat specific types of cancer, including endometrial cancer, when certain conditions are met. It belongs to a class of medications called PD-1 inhibitors, which help the immune system recognize and attack cancer cells. This medication is typically administered by a healthcare professional in a clinical setting.

Side Effects

As an immunotherapy, Dostarlimab may help reduce tumor size or slow cancer progression in eligible patients. Some individuals experience immune-related side effects as the body’s response adjusts. Common effects may include fatigue, nausea, or skin reactions, though these vary by person.

Precautions & Warnings

Store Dostarlimab at 2-8°C and protect from light. Handle with care to avoid contamination or breakage, as this is an injectable medication. Always ensure proper disposal of used ampoules and follow local guidelines for pharmaceutical waste.

Avoid Interactions

Dostarlimab may interact with other immunotherapies or medications that weaken the immune system, such as corticosteroids. Avoid live vaccines during treatment unless approved by a doctor. Discuss all current medications with your healthcare provider before starting Dostarlimab.

Frequently Asked Questions

Dostarlimab is used to treat certain types of cancer, such as endometrial cancer, under specific medical conditions.

Dostarlimab is given as an injection by a healthcare professional, typically in a clinical or hospital setting.

Common effects may include fatigue, nausea, or skin reactions, though individual experiences vary.

No, Dostarlimab should be stored at 2-8°C and protected from light.

It may interact with other immunotherapies or immune-weakening drugs; consult your doctor for details.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.